Search for other papers by Alice S Ryan in
Google Scholar
PubMed
Search for other papers by John C McLenithan in
Google Scholar
PubMed
Search for other papers by Gretchen M Zietowski in
Google Scholar
PubMed
Introduction Women with a history of gestational diabetes mellitus (GDM) are at an increased risk for the development of type 2 diabetes mellitus (T2DM) within 5 years following pregnancy (1, 2) with the reported incidence of T2DM ranging from
Search for other papers by Yun Cai in
Google Scholar
PubMed
Search for other papers by Jieni Yan in
Google Scholar
PubMed
Search for other papers by Yong Gu in
Google Scholar
PubMed
Search for other papers by Heng Chen in
Google Scholar
PubMed
Search for other papers by Yang Chen in
Google Scholar
PubMed
Search for other papers by Xinyu Xu in
Google Scholar
PubMed
Search for other papers by Mei Zhang in
Google Scholar
PubMed
Search for other papers by Liping Yu in
Google Scholar
PubMed
Search for other papers by Xuqin Zheng in
Google Scholar
PubMed
Search for other papers by Tao Yang in
Google Scholar
PubMed
’ hyperthyroidism, while TGAb and TPOAb are more characteristic for HT, which is correlated with thyroidal damage and lymphocytic inflammation ( 1 , 2 ). Individuals with AITD may be associated with other autoimmune diseases, of which type 1 diabetes mellitus (T1
Search for other papers by Giovanni Fanni in
Google Scholar
PubMed
Search for other papers by Petros Katsogiannos in
Google Scholar
PubMed
Search for other papers by Bipasha Nandi Jui in
Google Scholar
PubMed
Search for other papers by Magnus Sundbom in
Google Scholar
PubMed
Search for other papers by Susanne Hetty in
Google Scholar
PubMed
Search for other papers by Maria J Pereira in
Google Scholar
PubMed
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
Introduction Besides inducing significant and durable weight loss, Roux-en-Y gastric bypass (RYGB) improves glycemic control in insulin-resistant patients and can prevent or reverse type 2 diabetes mellitus (T2DM) ( 1 , 2 , 3 ). This
Search for other papers by Shaomin Shi in
Google Scholar
PubMed
Search for other papers by Xinghua Chen in
Google Scholar
PubMed
Search for other papers by Wen Yu in
Google Scholar
PubMed
Search for other papers by Xiaolan Ke in
Google Scholar
PubMed
Search for other papers by Tean Ma in
Google Scholar
PubMed
Lang Y Yang W Yang F Yang J Wu Y Xiao X Qin C Zou Y Zhao Y , Efficacy and safety of drugs for people with type 2 diabetes mellitus and chronic kidney disease on kidney and cardiovascular outcomes: a systematic review and network meta
Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden
Search for other papers by Bledar Daka in
Google Scholar
PubMed
Search for other papers by Thord Rosen in
Google Scholar
PubMed
Search for other papers by Per Anders Jansson in
Google Scholar
PubMed
Search for other papers by Lennart Råstam in
Google Scholar
PubMed
Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden
Search for other papers by Charlotte A Larsson in
Google Scholar
PubMed
Search for other papers by Ulf Lindblad in
Google Scholar
PubMed
−82 °C. In participants without known diabetes mellitus, an oral glucose tolerance test (OGTT) was performed to characterize the participants with impaired fasting glucose, impaired glucose tolerance, and diabetes mellitus according to WHO criteria
Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People’s Republic of China, Hefei, Anhui, China
NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Hefei, Anhui, China
Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, Hefei, Anhui, China
Search for other papers by Beibei Zhu in
Google Scholar
PubMed
Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People’s Republic of China, Hefei, Anhui, China
NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Hefei, Anhui, China
Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, Hefei, Anhui, China
Search for other papers by Yan Han in
Google Scholar
PubMed
Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People’s Republic of China, Hefei, Anhui, China
NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Hefei, Anhui, China
Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, Hefei, Anhui, China
Search for other papers by Fen Deng in
Google Scholar
PubMed
Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People’s Republic of China, Hefei, Anhui, China
NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Hefei, Anhui, China
Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, Hefei, Anhui, China
Search for other papers by Kun Huang in
Google Scholar
PubMed
Search for other papers by Shuangqin Yan in
Google Scholar
PubMed
Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People’s Republic of China, Hefei, Anhui, China
NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Hefei, Anhui, China
Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, Hefei, Anhui, China
Search for other papers by Jiahu Hao in
Google Scholar
PubMed
Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People’s Republic of China, Hefei, Anhui, China
NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Hefei, Anhui, China
Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, Hefei, Anhui, China
Search for other papers by Peng Zhu in
Google Scholar
PubMed
Key Laboratory of Population Health Across Life Cycle, Anhui Medical University, Ministry of Education of the People’s Republic of China, Hefei, Anhui, China
NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract, Hefei, Anhui, China
Anhui Provincial Key Laboratory of Population Health and Aristogenics, Anhui Medical University, Hefei, Anhui, China
Search for other papers by Fangbiao Tao in
Google Scholar
PubMed
diagnosed as gestational diabetes mellitus (GDM) is a highly prevalent complication during pregnancy and affects around 15–20% of pregnancies ( 4 ) and the world has been witnessing a rapid increase in GDM incidence ( 5 ). Its negative health consequences
Search for other papers by Yu Ah Hong in
Google Scholar
PubMed
Search for other papers by Kyung-Do Han in
Google Scholar
PubMed
Search for other papers by Jae-Seung Yun in
Google Scholar
PubMed
Search for other papers by Eun Sil Sil in
Google Scholar
PubMed
Search for other papers by Seung-Hyun Ko in
Google Scholar
PubMed
Search for other papers by Sungjin Chung in
Google Scholar
PubMed
Introduction Diabetic nephropathy is a major microvascular complication of type 2 diabetes mellitus (DM), and in many countries of the world, it is the major cause of end-stage renal disease (ESRD) ( 1 , 2 , 3 ). Identification of high
Search for other papers by Yu Lin in
Google Scholar
PubMed
Search for other papers by Yingying Zhang in
Google Scholar
PubMed
Search for other papers by Lei Xu in
Google Scholar
PubMed
Search for other papers by Wei Long in
Google Scholar
PubMed
Search for other papers by Chunjian Shan in
Google Scholar
PubMed
Search for other papers by Hongjuan Ding in
Google Scholar
PubMed
Search for other papers by Lianghui You in
Google Scholar
PubMed
Search for other papers by Chun Zhao in
Google Scholar
PubMed
Search for other papers by Zhonghua Shi in
Google Scholar
PubMed
Y et al . Dysbiosis of maternal and neonatal microbiota associated with gestational diabetes mellitus . Gut 2018 67 1614 – 1625 . ( https://doi.org/10.1136/gutjnl-2018-315988 ) 36 Huo L Lyons J Magliano DJ Infectious and environmental
Search for other papers by Clarissa Souza Barthem in
Google Scholar
PubMed
Laboratório de Fisiologia Endócrina Doris Rosenthal, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Camila Lüdke Rossetti in
Google Scholar
PubMed
Search for other papers by Denise P Carvalho in
Google Scholar
PubMed
Search for other papers by Wagner Seixas da-Silva in
Google Scholar
PubMed
has become one of the most prescribed antidiabetic drugs worldwide. Although the mechanism of action of metformin is not fully understood ( 10 ), metformin is widely used for the treatment of metabolic disorders found in type 2 diabetes mellitus
Search for other papers by Sarantis Livadas in
Google Scholar
PubMed
Search for other papers by Christina Bothou in
Google Scholar
PubMed
Search for other papers by Justyna Kuliczkowska-Płaksej in
Google Scholar
PubMed
Search for other papers by Ralitsa Robeva in
Google Scholar
PubMed
Search for other papers by Andromahi Vryonidou in
Google Scholar
PubMed
Search for other papers by Jelica Bjekic Macut in
Google Scholar
PubMed
Search for other papers by Ioannis Androulakis in
Google Scholar
PubMed
Search for other papers by Milica Opalic in
Google Scholar
PubMed
Search for other papers by Zadalla Mouslech in
Google Scholar
PubMed
Search for other papers by Andrej Milewicz in
Google Scholar
PubMed
Search for other papers by Alessandra Gambineri in
Google Scholar
PubMed
Search for other papers by Dimitrios Panidis in
Google Scholar
PubMed
Search for other papers by Djuro Macut in
Google Scholar
PubMed
, accompanied by oligomenorrhea, dominate the clinical picture followed by metabolic disorders including dysglycemia and dyslipidemia later in life ( 1 ). Moreover, progression of normoglycemia to either intermediate hyperglycemia or diabetes mellitus (T2DM) has